Compass Therapeutics, Inc. Common Stock (CMPX) is a publicly traded Healthcare sector company. As of July 22, 2026, CMPX trades at $2.11 with a market cap of $363.78M and a P/E ratio of -4.94. CMPX moved +0.48% today. Year to date, CMPX is -60.89%; over the trailing twelve months it is -31.60%. Its 52-week range spans $1.33 to $6.88. Analyst consensus is strong buy with an average price target of $9.38. Rallies surfaces CMPX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CMPX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $2.11 |
| Market Cap | $363.78M |
| P/E Ratio | -4.94 |
| EPS | $-0.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.88 |
| 52-Week Low | $1.33 |
| Volume | 593 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-66.49M |
| Gross Margin | 0.00% |
11 analysts cover CMPX: 0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.38.